Angiodynamics Inc (ANGO) Files Form 4 Insider Selling : Charles R Greiner Sells 3,508 Shares

Angiodynamics Inc (ANGO): Charles R Greiner , VP – Global Franchise of Angiodynamics Inc sold 3,508 shares on May 6, 2016. The Insider selling transaction was reported by the company on May 9, 2016 to the Securities and Exchange Commission. The shares were sold at $12.31 per share for a total value of $43,183.48 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 25, 2016, Stephen A Trowbridge (SVP and General Counsel) sold 12,940 shares at $12.26 per share price.On Feb 19, 2015, Stark Richard (SVP, GM – Oncology) sold 18,100 shares at $18.53 per share price.

AngioDynamics: On Friday, May 6, 2016 heightened volatility was witnessed in AngioDynamics which led to swings in the share price. The shares opened for trading at $12.27 and hit $12.49 on the upside , eventually ending the session at $12.46, with a gain of 1.38% or 0.17 points. The heightened volatility saw the trading volume jump to 1,46,555 shares. The 52-week high of the share price is $17 and the company has a market cap of $453 M . The 52-week low of the share price is at $9.71.

AngioDynamics Money Flow Index Chart

Company has been under the radar of several Street Analysts.AngioDynamics is Resumed by Piper Jaffray to Neutral. The Rating was issued on Apr 8, 2016.

AngioDynamics Inc. designs manufactures and sells a range of medical surgical and diagnostic devices used by professional healthcare providers for vascular access for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular Vascular Access and Oncology/Surgery. The Company’s Peripheral Vascular products include fluid management venous thrombus management as well as other core products. The Company’s BioFlo products incorporate Endexo technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its microwave ablation products its radiofrequency ablation (RFA) and its NanoKnife product lines.

Leave a Reply

AngioDynamics - Is it time to Sell?

Top Brokerage Firms are advising their investors on AngioDynamics. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.